Improving heart imaging technologies for better diagnosis of coronary artery disease
Development of advanced cardiac SPECT imaging technologies
This study is looking at new ways to take clearer pictures of the heart to help doctors better diagnose and treat coronary artery disease, so patients can get more accurate information about their heart health and personalized care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10673649 on NIH RePORTER |
What this research studies
This research focuses on enhancing cardiac imaging techniques using advanced Single Photon Emission Computed Tomography (SPECT) to improve the diagnosis and management of coronary artery disease (CAD). By optimizing dedicated cardiac scanners, the project aims to increase the sensitivity and resolution of heart imaging, allowing for better detection of conditions like ischemia and infarction. The study will explore new applications such as ultra-low-dose imaging and high-resolution molecular imaging, which could lead to more accurate assessments of heart health. Patients may benefit from more precise diagnoses and tailored treatment plans based on improved imaging results.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with suspected or diagnosed coronary artery disease who require advanced imaging for better evaluation.
Not a fit: Patients without coronary artery disease or those who do not require imaging for heart conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and safer heart imaging, improving patient outcomes in the diagnosis and management of coronary artery disease.
How similar studies have performed: Previous advancements in cardiac imaging technologies have shown promising results, indicating that this approach has the potential for significant clinical impact.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Liu, Chi — Yale University
- Study coordinator: Liu, Chi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.